Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Dysfunction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05283915
What this trial is testing

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic Function Abnormal
Sanofi 10
Not applicableNot Yet RecruitingNCT07684248
What this trial is testing

Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Type 1 Diabetes
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 200
Not applicableUnknownNCT06179368
What this trial is testing

Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome

Who this might be right for
Hepatic EncephalopathyHepatic ImpairmentHypothyroidism+1 more
Assiut University 100
Not applicableNot Yet RecruitingNCT07285135
What this trial is testing

Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Singapore General Hospital 60
Not applicableNot Yet RecruitingNCT07793279
What this trial is testing

Hypothyroidism and Liver Fibrosis Severity in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHypothyroidismLiver Cirrhosis+1 more
Assiut University 85
Not applicableStudy completedNCT01700231
What this trial is testing

Plasma and Hemodynamic Markers During Hepatectomy

Who this might be right for
Hepatorenal Syndrome, Liver Regeneration
Medical University of Vienna 100
Not applicableEnded earlyNCT01809782
What this trial is testing

Cognitive Outcome After Two-stage Liver-Operation

Who this might be right for
Delirium and Post-operative Cognitive Dysfunction (POCD)
Charite University, Berlin, Germany 23
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Not applicableWithdrawnNCT03864835
What this trial is testing

NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Milton S. Hershey Medical Center
Not applicableNot Yet RecruitingNCT06749340
What this trial is testing

Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis

Who this might be right for
Coginitive DysfunctionCompensated Liver CirrhosisPhysical Dysfunction+1 more
Bahçeşehir University 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07663643
What this trial is testing

Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Cirrhosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 459
Testing effectiveness (Phase 2)Study completedNCT00600938
What this trial is testing

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Who this might be right for
Transfusional Iron OverloadTransfusional Hemosiderosis
Novartis Pharmaceuticals 197
Testing effectiveness (Phase 2)Study completedNCT01876108
What this trial is testing

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverLiver DysfunctionInsulin Resistance
Tehran University of Medical Sciences 100
Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Not applicableStudy completedNCT03376009
What this trial is testing

Novel Biomarkers of Kidney Dysfunction at Liver Transplant

Who this might be right for
Liver TransplantationLiver Transplant; ComplicationsKidney Dysfunction
University of Edinburgh 55
Not applicableNot Yet RecruitingNCT06907563
What this trial is testing

Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Who this might be right for
Steatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Steatotic Liver Disease of Mixed Origin (MetALD)+1 more
Universität des Saarlandes 30,000
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Looking for participantsNCT07459504
What this trial is testing

SMART Diets for MASLD

Who this might be right for
Metabolic-dysfunction Associated Steatotic Liver Disease
Michigan State University 102
Large-scale testing (Phase 3)UnknownNCT06759363
What this trial is testing

MASLD Butyrate Supplementation Treatment Efficacy Review

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University Medical Center Zvezdara 200
Testing effectiveness (Phase 2)Ended earlyNCT00550849
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

Who this might be right for
Liver Disease
Biogen 16
Next Page